On July 20, 2018, Liao Yongping, Director of Lishui Forestry Bureau, led a delegation to visit Zhejiang Benefit Pharmaceutical Co., Ltd. for research and guidance. Wu Lihua, Chairman of the company, and senior executives of the pharmaceutical company warmly received them.

Accompanied by the company's senior management, Director Liao and his entourage visited the production workshop, laboratory and warehousing logistics center, gaining an in-depth understanding of the production status, R&D and quality control of the company's traditional Chinese medicine decoction pieces and traditional Chinese medicine formula granules.

(Visiting the warehousing logistics center)

(Visiting the laboratory and R&D center)

At the symposium, Chairman Wu Lihua first expressed his welcome and sincere thanks to Director Liao and his entourage for their visit, and made a detailed report on the company's growth history, development status, as well as the production, R&D and sales of traditional Chinese medicine formula granules. He also focused on elaborating that Benefit Pharmaceutical has a differentiated positioning in the development of products and scientific research compared with other peers, which is more conducive to the industrialization of scientific research achievements.

After listening to the report, Director Liao Yongping stated that Zhejiang Benefit Pharmaceutical Co., Ltd., as a manufacturer of traditional Chinese medicine formula granules, has a very correct development positioning in terms of product quality control standards, requirements and scientific research directions. He hoped that Benefit would better integrate the "Two Mountains Theory", take advantage of Lishui's good environment and large space, vigorously promote the industrialization of green ecological resources, develop green people-benefiting projects - under-forest economy according to local conditions, support the company in researching and developing local authentic medicinal materials such as Polygonatum sibiricum, Tetrastigma hemsleyanum, and Ganoderma lucidum broken spore powder, realize the corporate strategy of "large products, large brands, large industries", achieve ecological prosperity for the people, and boost the influence of local green Chinese medicinal materials industry brands.

Linked development, cultivating high-quality products

Consolidating brands, nurturing leading enterprises

As an inheritor and innovator of modern traditional Chinese medicine, Zhejiang Benefit Pharmaceutical Co., Ltd. will surely stand at the forefront, actively establish a scientific research platform for Chinese medicinal materials, strive to promote the upward development of scientific research achievements of authentic medicinal materials, convert more theoretical results into industrialization, and provide continuous impetus for the development of traditional Chinese medicine.